JSF Financial
GILD icon

JSF Financial’s Gilead Sciences GILD Stock Holding History

JSF Financial’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-10,083
Closed -$1.27M – 153
2026
Q2 		$1.27M Buy
10,083
+432
+4% +$56.9K 0.2% 69
2026
Q1 		$1.35M Sell
9,651
-513
-5% -$71.8K 0.26% 49
2025
Q4 		$1.25M Buy
+10,164
New +$1.24M 0.26% 52

Other funds holding GILD

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

JSF Financial's GILD Position: Q3 2026 in Review

JSF Financial sold out of Gilead Sciences (GILD) in Q3 2026, closing a stake of 10,083 shares — an estimated $1.27M sold.

JSF Financial first reported a position in GILD in Q4 2025 and held it in 3 quarters. The position peaked at $1.35M in Q1 2026. 2,060 funds tracked by Wall St. Rank hold GILD as of Q3 2026.

  • JSF Financial reported no remaining Gilead Sciences position as of Q3 2026 after selling out during the quarter.
  • JSF Financial sold 10,083 Gilead Sciences shares in Q3 2026, an estimated $1.27M.
  • JSF Financial first reported a position in Gilead Sciences in Q4 2025 and held it in 3 quarters.
  • JSF Financial's Gilead Sciences position peaked at $1.35M in Q1 2026.
  • 2,060 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.

Based on JSF Financial's 13F filing for Q3 2026, filed 22 Oct 2026.